common.study.topics.clinical

Annoveraâ„¢ Drug-Drug Interaction Study

common.study.values.description

Annoveraâ„¢ Drug-Drug Interaction Study

A Drug-Drug Interaction (DDI) study to evaluate the effects of itraconazole and rifampin on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol from the Annovera Contraceptive Vaginal System (CVS)

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Segesterone Acetate and Ethinyl Estradiol

Contraceptive Vaginal System

Drug - Rifampin

CYP3A inducer

Drug - Itraconazole

CYP3A inhibitor

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Drug-Drug Interaction Study to Evaluate the Effects of Strong CYP3A Induction and Inhibition on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol From the Annoveraâ„¢ Contraceptive Vaginal System

common.study.values.clinical-trial-id

NCT04290390

participant.views.study.view.id

egJvZd